Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection.
AUTOR(ES)
Wong, K L
RESUMO
Serum soluble interleukin 2 receptor (sIL2R) was measured in patients with active and inactive systemic lupus erythematosus (SLE). The concentration of sIL2R was higher in inactive SLE than in normal controls and was significantly increased in active compared with inactive SLE. When patients with active SLE were followed up serially it was found that the sIL2R concentration fell when the disease became inactive. There was no statistically significant association between sIL2R and the grades of disease activity, however. In patients with either active or inactive SLE and infection the sIL2R concentration was much higher than in those without infection. Chronic infection (tuberculosis or candida) was associated with a much higher concentration of sIL2R than pyogenic or herpes zoster infection. The sIL2R concentration helps to distinguish infection in patients with SLE.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1004536Documentos Relacionados
- Interleukin-17 and systemic lupus erythematosus: current concepts
- Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.
- Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
- Heart Disease in Systemic Lupus Erythematosus: Diagnosis and Management
- Heart Disease in Systemic Lupus Erythematosus: Diagnosis and Management
